[1] PAPANIKOLAOU P, ANTONOPOULOS AS, MASTORAKOU I, et al. Antithrombotic therapy in carotid artery disease. Curr Pharm Des. 2020;26(23):2725-2734
[2] LI W, ZHAO J, SONG L, et al. Combined effects of carotid plaques and hypertension on the risk of cardiovascular disease and all-cause mortality. ClinCardiol. 2020;43(7):715-722.
[3] LEPILINA A, COON AN, KIKUCHI K, et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell. 2006;127(3):607-619.
[4] TSENG CC, RAMJANKHAN FZ, DE JONGE N, et al. Advanced strategies for end-stage heart failure: combining regenerative approaches with LVAD, a new horizon? Front Surg. 2015;2:10.
[5] SONG SY, KIM H, YOO J, et al. Prevascularized, multiple-layered cell sheets of direct cardiac reprogrammed cells for cardiac repair. Biomater Sci. 2020; 8(16):4508-4520.
[6] 陈悦,陈超美,胡志刚,等.引文空间分析原理与应用CiteSpace实用指南[M].北京:科学出版社,2014:27-69.
[7] 陈悦,陈超美,刘则渊,等.CiteSpace知识图谱的方法论功能[J].科学学研究,2015,33(2):242-253.
[8] RANGAPPA S, ENTWISTLE JWC, WECHSLER AS, et al. Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thor Cardiovasc Surg. 2003;126(1):124-132.
[9] IEDA M, FU JD, DELGADO-OLGUIN P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010;142(3):375-386.
[10] QIAN L, HUANG Y, SPENCER CI, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature. 2012;485 (7400):593-598.
[11] WANG L, LIU Z, YIN C, et al. Stoichiometry of Gata4, Mef2C, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circ Res. 2015;116(2):237-244.
[12] 邱均平.信息计量学[M].武汉:武汉大学出版社,2007:91.
[13] PASSIER R, OOSTWAARD DW, SNAPPER J, et al.Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells. 2005;23(6):772-780.
[14] TAKAHASHI K, TANABE K, OHNUKI M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-872.
[15] HUANG P, HE Z, JI S, et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature. 2011;475 (7356):386-389.
[16] INAGAWA K, MIYAMOTO K, YAMAKAWA H, et al. Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ Res. 2012;111(9):1147-1156.
[17] RYU J, HWANG NS, PARK HH, et al. Protein-based direct reprogramming of fibroblasts to neuronal cells using 30Kc19 protein and transcription factor Ascl1. Int J Biochem Cell Biol. 2020;121:105717.
[18] XIAO D, LIU X, ZHANG M, et al. Direct reprogramming of fibroblasts into neural stem cells by single non-neural progenitor transcription factor Ptf1a. Nat Commun. 2018;9(1):2865.
[19] WANG L, HUANG P, NEAR D, et al. Isoform specific effects of mef2c during direct cardiac reprogramming. Cells. 2020;9(2):268.
[20] TANI H, SADAHIRO T, IEDA M. Direct cardiac reprogramming: a novel approach for heart regeneration. Int J Mol Sci. 2018;19(9):2629.
[21] JAYAWARDENA TM, EGEMNAZAROV B, FINCH EA, et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res. 2012;110(11):1465-1473.
[22] YU J, VODYANIK MA, SMUGA-OTTO K, et al.Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318 (5858):1917-1920.
[23] PORRELLO ER, MAHMOUD AI, SIMPSON E, et al. Transient regenerative potential of the neonatal mouse heart. Science. 2011;331(6020): 1078-1080.
[24] BERGMANN O, BHARDWAJ RD, BERNARD S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324(5923):98-102.
[25] PROTZE S, KHATTAK S, POULET C, et al. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol. 2012;53(3):323-332.
[26] VIERBUCHEN T, OSTERMEIER A, PANG ZP, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010; 463(7284):1035-1041.
[27] SEKIYA S, SUZUKI A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature. 2011;475(7356):390-393.
[28] EFE JA, HILCOVE S, KIM J, et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol. 2011;13(3):215-222.
[29] CHEN JX, KRANE M, DEUTSCH MA, et al. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res. 2012;111(1):50-55.
[30] MURAOKA N, YAMAKAWA H, MIYAMOTO K, et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J. 2014;33(14):1565-1581.
[31] ZHAO Y, LONDONO P, CAO Y, et al. High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling. Nat Commun. 2015;6:8243.
[32] YAMAKAWA H, MURAOKA N, MIYAMOTO K, et al. Fibroblast growth factors and vascular endothelial growth factor promote cardiac reprogramming under defined conditions. Stem Cell Rep. 2015;5(6):1128-1142.
[33] MATHISON M, GERSCH RP, NASSER A, et al. In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc. 2012;1(6):e005652.
|